Tuesday, September 28, 2021
wellness India Expo
Home Tags Trial

Tag: Trial

India’s first mRNA-based Covid-19 vaccine gets DCGI nod for Phase II...

The trial for India’s first mRNA-based vaccine from Gennova Biopharmaceuticals was found to be safe in Phase I study. Post Drugs Controller General of India approval, Phase II and Phase III trials are to commence in early September, 2021......................

Zydus completes Phase-I trials of its anti-malarial compound

Phase I healthy volunteers study demonstrated long half-life and potential for a single-dose cure for malaria. Potent antimalarial activity demonstrated in malaria challenge trial following single-dose oral administration of ZY19489.......................

Record 59 new US drugs launched in 2018, success rates fall:...

As per the study by IQVIA Institute for Human Data Science, while the likelihood that a drug entering clinical development would be a success was 11 percent, down from 14 percent in 2017, eight identified trends could increase R&D productivity by double digits during next five years.................

Vyome raises $22M to advance dermatology pipeline

The formerly India-based Vyome Therapeutics has relocated to Princeton NJ in tandem with closing a $22 million-dollar Series D financing to advance their pipeline of dermatological therapeutics capable of overcoming antimicrobial resistance...……...

Steroid treatment associated with high-risk of adverse events for kidney disease

A study by The George Institute for Global Health has found unexpectedly large increase in the risk of serious adverse events, primarily infections among patients with IgA nephropathy and excess protein in their urine.........

ISCR announces results of international clinical trials day patient logo contest

ISCR’s logo design contest for patients was a creative way of integrating patients into the commemoration....